IRulya Therapeutics Inc. IRLA · News

IRulya Therapeutics is a clinical-stage biopharmaceutical company developing LAM-001, an inhaled for...

Price33.775

Market Cap366.22 M

Float10.8 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Search in Documents